So I was deep diving into
$NASA ETF holdings to see what will heavily benefit from
$SPCX IPO...
And I came across
$CPSH. At the start of this year, it was a solid US AlSiC play, but quickly became a multi-thesis bet.
As of last week,
$NASA ETF holds ~1.8M shares of
$CPSH (I immediately started a relatively large position).
This is important because
$NASA is the only pure-play space ETF with direct SpaceX exposure pre-IPO.
And a portion of every dollar flowing into
$NASA for SpaceX exposure becomes a purchase of
$CPSH. As SpaceX IPO momentum builds toward June 12, that flow accelerates.
But let's go over why
$CPSH even made the cut into
$NASA's portfolio. At the beginning of 2026:
> It was the only meaningful US/Western hedge against East Asian AlSiC supply (Denka, Sumitomo, JFC, etc.)
> Existing customers: US Military, NASA,
$LMT,
$RTX, Northrop, General Dynamics, and more
> AI optionality as
$NVDA Rubin generation scales towards multi-thousand watt requirements (this angle alone deserves a whole new post)
And the foundation has only gotten stronger...
> Record 2025 annual revenue of $32.6M and Q4 2025 revenue $8.2M vs $5.9M prior year ( 39% YoY). Q4 gross margin recovered to 14.6% from a Q4 2024 gross loss
> New $4M hermetic packaging order announced post-Q1
> Navy SBIR office extended Phase I program for Amphibious Combat Vehicles
> Potential US Navy destroyer ballistic shield contracts with Congressional funding already secured
Now add the
$NASA ETF layer...
Large asymmetry here.